GV

About

Portfolio · 8

Pecan AI

Deep-learning Predictive Analytics Platform

1 round $66.0M committed Latest: 2022-02

Nym

Natural Language Understanding for Automated Healthcare Coding

Led ★ 2 rounds $41.5M committed Latest: 2021-07

Simply

Music Education Apps

Led ★ 1 round $50.0M committed Latest: 2021-06

Nanit

Smart Baby Monitor and Sleep Tracker Devices

Led ★ 1 round $25.0M committed Latest: 2021-02

Viz.ai

AI-powered Intelligent Care Coordination

2 rounds $71.0M committed Latest: 2019-10

Snyk

Developer Security Platform

1 round $70.0M committed Latest: 2019-09

Lemonade

AI-driven Insurance Provider

1 round $34.0M committed Latest: 2016-12

Q.AI

Communication Enhancement Technology

1 round

Investment activity

1 portfolio exit on record.

Q&A

What is GV's primary investment focus?

GV is a venture capital firm that invests in innovative startups across various industries, including technology, life sciences, and consumer products. Their focus is on long-term growth.

Which sectors does GV most frequently invest in?

GV shows a strong concentration in Health Tech & Life Sciences, with 6 investment rounds and 4 portfolio companies in this sector. They also have investments in Business Software, Education & Knowledge Technologies, Cyber Security, and Fintech & Insurtech.

Can you name some of GV's notable portfolio companies?

GV's portfolio includes Snyk, a developer security platform that has raised $1.58B, and Lemonade, an AI-driven insurance provider that went public in July 2020 with a valuation of $1.6B.

What is GV's typical investment stage?

GV invests across various stages, including Seed, Pre-Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round. Their recent activity includes investments in Seed and A Round

Has GV had any significant exits recently?

GV had a notable exit in July 2020 when their portfolio company Lemonade went public on the NYSE with a valuation of $1.6B.

What is the most recent investment round GV participated in?

GV participated in an A Round for Syremis Therapeutics in December 2025, which raised $165M.

Which portfolio company of GV is focused on natural language understanding for healthcare coding?

GV's portfolio company Nym focuses on Natural Language Understanding for Automated Healthcare Coding. Nym has raised $94.5M in funding.

What is the investment range for GV?

According to startupim data, GV's investment range is between $16.5M and $165M.